Rajiv Patni

Insider Reports History

Location
New Haven, CT
Signature
/s/ Richard Steinhart, Attorney-in-Fact for Rajiv Patni
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rajiv Patni:

Company Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. Director Director Stock Option (Right to Buy) 27,000 04 Jun 2025 Direct
BioXcel Therapeutics, Inc. Director Stock Option (Right to Buy) 17,000 09 Jan 2026 Direct
Quince Therapeutics, Inc. Director Employee Stock Option (right to buy) 13,500 05 Jun 2024 Direct
REATA PHARMACEUTICALS INC EVP, Chief R&D Officer Class A common stock 0 $172.03 26 Sep 2023 Direct
REATA PHARMACEUTICALS INC EVP, Chief R&D Officer Employee Stock Option (right to buy) 0 26 Sep 2023 Direct

Insider Reports Filed by Rajiv Patni

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BTAI BioXcel Therapeutics, Inc. 09 Jan 2026 1 $0 4 Director 12 Jan 2026, 19:08
QNCX Quince Therapeutics, Inc. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 17:14
BTAI BioXcel Therapeutics, Inc. 15 Jan 2025 1 $0 4 Director 16 Jan 2025, 08:04
BTAI BioXcel Therapeutics, Inc. 15 Jan 2025 0 $0 3 Director 16 Jan 2025, 08:03
QNCX Quince Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 20:55
QNCX Quince Therapeutics, Inc. 15 Feb 2024 1 $0 4 Director 15 Feb 2024, 18:14
QNCX Quince Therapeutics, Inc. 15 Feb 2024 0 $0 3 Director 15 Feb 2024, 18:09
/report/000089924323019537-patni-rajiv-2023-09-26 REATA PHARMACEUTICALS INC 26 Sep 2023 2 $0 4 EVP, Chief R&D Officer 26 Sep 2023, 16:30
/report/000120919123037021-patni-rajiv-2023-06-12 REATA PHARMACEUTICALS INC 12 Jun 2023 2 $0 4 EVP, Chief R&D Officer 14 Jun 2023, 16:26
/report/000120919123037013-patni-rajiv-2023-06-12 REATA PHARMACEUTICALS INC 12 Jun 2023 0 $0 3 EVP, Chief R&D Officer 14 Jun 2023, 16:20